It’s time for another dive into the biggest pre-market stock movers as we check out the latest news for Tuesday!
Moving stocks are clinical trial news, acquisition agreements, and more this morning.
Let’s get into that news below!
Pre-Market Stock Movers: 10 Top Gainers
- Virios Therapeutics (NASDAQ:VIRI) stock is rocketing more than 44% from a Phase 3 clinical trial.
- Spectrum Pharma (NASDAQ:SPPI) shares are soaring over 33% thanks to with Assertio (NASDAQ:ASRT).
- ZeroFox (NASDAQ:ZFOX) stock is surging more than 31% after of LookingGlass.
- SeqLL (NASDAQ:SQL) shares are increasing 20% without any recent news.
- 1847 Holdings (NYSEMKT:EFSH) stock is climbing over 17% as it continues a rally on a .
- CXApp (NASDAQ:CXAI) shares are rising close to 16% following a dip yesterday.
- Agrify (NASDAQ:AGFY) stock is gaining more than 14% after and .
- Aarons (NYSE:AAN) shares are heading over 12% higher .
- Citius Pharma (NASDAQ:CTXR) stock is jumping more than 9% with an update on .
- Liquid Media Group (NASDAQ:YVR) shares are up over 9% on Tuesday morning.
10 Top Losers
- Vyant Bio (NASDAQ:VYNT) stock is crashing more than 45% after .
- TRACON Pharma (NASDAQ:TCON) shares are plummeting over 34% following for I-Mab (NASDAQ:IMAB).
- Netcapital (NASDAQ:NCPL) stock is diving more than 26% on Tuesday morning.
- MAIA Biotechnology (NYSEMKT:MAIA) shares are tumbling over 23% after .
- Appreciate (NASDAQ:SFR) stock is sliding more than 21% this morning.
- First Republic Bank (NYSE:FRC) shares are taking a nearly 21% beating .
- NextPlat (NASDAQ:NXPL) stock is decreasing over 17% after Robert D. Keyser., Jr acquired .
- Assertio (NASDAQ:ASRT) shares are slipping more than 16% after announcing Spectrum Pharmaceuticals (NASDAQ:SPPI).
- Tempo Automation (NASDAQ:TMPO) stock is dipping over 15% after rallying on Monday.
- Lightning eMotors (NYSE:ZEV) shares close out our pre-market stock movers down almost 13% after .
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.